# Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)

> **NCT00752362** · PHASE4 · COMPLETED · sponsor: **Sahajanand Medical Technologies Limited** · enrollment: 280 (actual)

## Conditions studied

- Coronary Restenosis

## Interventions

- **DEVICE:** Milennium Matrix® (Control)
- **DEVICE:** Infinnium®
- **DEVICE:** Supralimus®

## Key facts

- **NCT ID:** NCT00752362
- **Lead sponsor:** Sahajanand Medical Technologies Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-05
- **Final completion:** —
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2015-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00752362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00752362, "Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00752362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*